Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation

American Journal of Chinese Medicine

Volumn 42, Issue 5, 2014, Pages 1153-1167

  El Bassossy, Hany M ^a,b   Abo Warda, Shaymaa M ^b   Fahmy, Ahmed ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Zagazig University   (Egypt)

Author keywords

Aorta; BADGE; Chrysin; Insulin Resistance; Luteolin; PPAR

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ACETYLCHOLINE; ADVANCED GLYCATION END PRODUCT; BISPHENOL A DIGLYCIDYL ETHER; CHOLESTEROL; CHRYSIN; DRINKING WATER; FRUCTOSE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEOLIN; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENYLEPHRINE; POTASSIUM CHLORIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; 2,2-BIS(4-GLYCIDYLOXYPHENYL)PROPANE; 2-CHLORO-5-NITROBENZANILIDE; ANILIDE; BENZHYDRYL DERIVATIVE; EPOXIDE; FLAVONOID; GLUCOSE BLOOD LEVEL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DYSLIPIDEMIA; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BILE LEVEL; MALE; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD PRESSURE; DRUG EFFECTS; HYPERINSULINISM; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANILIDES; ANIMALS; AORTA, THORACIC; BENZHYDRYL COMPOUNDS; BLOOD GLUCOSE; BLOOD PRESSURE; EPOXY COMPOUNDS; FLAVONOIDS; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPERINSULINISM; IN VITRO TECHNIQUES; INSULIN; INSULIN RESISTANCE; LIPIDS; LUTEOLIN; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PPAR GAMMA; RATS; REACTIVE OXYGEN SPECIES; VASOCONSTRICTION;

EID: 84926126053     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X14500724     Document Type: Article

References (38)

1. Azevedo, M.F., C. Camsari, C.M. Sa, C.F. Lima, F. Fernandes and C. Pereira-Wilson. Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3. Phytother. Res. 24(Suppl 2): S220-S224, 2010.
2. Balamurugan, K. and J. Karthikeyan. Evaluation of the antioxidant and anti-inflammatory nature of luteolin in experimentally induced hepatocellular carcinoma. Biomed. Prevent. Nutr. 2: 86-90, 2012.
3. Cho, H., C.W. Yun, W.K. Park, J.Y. Kong, K.S. Kim, Y. Park, S. Lee and B.K. Kim. Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharmacol. Res. 49: 37-43, 2004.
4. Cohuet, G. and H. Struijker-Boudier. Mechanisms of target organ damage caused by hypertension: Therapeutic potential. Pharmacol. Amp. Ther. 111: 81-98, 2006.
5. Ding, L., D. Jin and X. Chen. Luteolin enhances insulin sensitivity via activation of PPAR gamma transcriptional activity in adipocytes. J. Nutr. Biochem. 21: 941-947, 2010.
6. Duan, S.Z., M.G. Usher and R.M. Mortensen. Peroxisome proliferator-activated receptor-mediated effects in the vasculature. Cir. Res. 102: 283-294, 2008.
7. El-Bassossy, H.M., A. Fahmy and D. Badawy. Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem. Tox. 49: 3007-3012, 2011.
8. El-Bassossy, H.M., N.N. El-Maraghy, H.M. El-Fayoumi and M.L. Watson. Haem oxygenase-1 induction protects against tumour necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery. Br. J. Pharmacol. 158: 1527-1535, 2009.
9. El-Bassossy, H.M., R. El-Fawal and A. Fahmy. Arginase inhibition alleviates hypertension associated with diabetes: Effect on endothelial dependent relaxation and NO production. Vascul. Pharmacol. 57: 194-200, 2012.
10. El-Bassossy, H.M., S.M. Abo-Warda and A. Fahmy. Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: Effect on lipid profile, AGEs and NO generation. Phytother. Res. 27: 1678-1684, 2013a.
11. El-Bassossy, H.M., R. El-Fawal, A. Fahmy and M.L. Watson. Arginase inhibition alleviates hypertension in the metabolic syndrome. Br. J. Pharmacol. 169: 693-703, 2013b.
12. Hassan, N., H.M. El-Bassossy and M.N. Zakaria. Heme oxygenase-1 induction protects against hypertension associated with diabetes: Effect on exaggerated vascular contractility. Naunyn Schmiedebergs Arch. Pharmacol. 386: 217-226, 2013.
13. Hsu, J.H., Y.C. Wu, I.M. Liu and J.T. Cheng. Dioscorea as the principal herb of Die-Huang-Wan, a widely used herbal mixture in China, for improvement of insulin resistance in fructose-rich chow-fed rats. J. Ethnopharmacol. 112: 577-584, 2007.
14. Huang, T.H.W., B.P. Kota, V. Razmovski and B.D. Roufogalis. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin. Pharmacol. Toxicol. 96: 3-14, 2005.
15. Inoue, I., K. Shino, S. Noji, T. Awata and S. Katayama. Expression of peroxisome proliferatoractivated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells. Biochem. Biophys. Res. Commun. 246: 370-374, 1998.
16. Jiang, H., Q. Xia, X. Wang, J. Song and I.C. Bruce. Luteolin induces vasorelaxion in rat thoracic aorta via calcium and potassium channels. Pharmazie 60: 444-447, 2005.
17. Kim, J.S. and C. Jobin. The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 115: 375-387, 2005.
18. Kiyici, S., C. Ersoy, A. Kaderli, M. Fazlioglu, F. Budak, C. Duran, O.O. Gul, D. Sigirli, I. Baran, E. Tuncel, E. Erturk and S. Imamoglu. Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients. Diabetes Res. Clin. Pract. 86: 44-50, 2009.
19. Lahiri, S., T. Sen and G. Palit. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats. Eur. J. Pharmacol. 609: 118-125, 2009.
20. Liang, Y.C., S.H. Tsai, D.C. Tsai, S.Y. Lin-Shiau and J.K. Lin. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett. 496: 12-18, 2001.
21. Lin, Y.T., Y.Z. Tseng and K.C. Chang. Aminoguanidine prevents fructose-induced arterial stiffening in wistar rats: Aortic impedance analysis. Exp. Biol. Med. 229: 1038-1045, 2004.
22. Mansour, S.M., A.K. Bahgat, A.S. El-Khatib and M.T. Khayyal. Ginkgo biloba extract (EGb 761) normalizes hypertension in 2K, 1C hypertensive rats: Role of antioxidant mechanisms, ACE inhibiting activity and improvement of endothelial dysfunction. Phytomedicine 18: 641-647, 2011.
23. Marx, N., H. Duez, J.C. Fruchart and B. Staels. Peroxisome proliferator-activated receptors and atherogenesis: Regulators of gene expression in vascular cells. Circ. Res. 94: 1168-1178, 2004.
24. Marx, N. and D. Walcher. Vascular effects of PPAR gamma activators-From bench to bedside. Prog. Lipid Res. 46: 283-296, 2007.
25. Park, H.S., S.H. Kim, Y.S. Kim, S.Y. Ryu, J.T. Hwang, H.J. Yang, G.H. Kim, D.Y. Kwon and M.S. Kim. Luteolin inhibits adipogenic differentiation by regulating PPAR-activation. Biofactors 35: 373-379, 2009.
26. Pushpavalli, G., P. Kalaiarasi, C. Veeramani and K.V. Pugalendi. Effect of chrysin on hepatoprotective and antioxidant status in D-galactosamine-induced hepatitis in rats. Eur. J. Pharmacol. 631: 36-41, 2010.
27. Qian, L.B., H.P. Wang, Y. Chen, F.X. Chen, Y.Y. Ma, I.C. Bruce and Q. Xia. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress. Pharmacol. Res. 61: 281-287, 2010.
28. Reaven, G.M. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J. Clin. Endocrinol. Metab. 88: 2399-2403, 2003.
29. Sampathkumar, R., M. Balasubramanyam, M. Rema, C. Premanand and V. Mohan. A novel advanced glycation index and its association with diabetes and microangiopathy. Metabolism 54: 1002-1007, 2005.
30. Steinberg, H.O., H. Chaker, R. Leaming, A. Johnson, G. Brechtel and A.D. Baron. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97: 2601-2610, 1996.
31. Suwannaphet, W., A. Meeprom, S. Yibchok-Anun and S. Adisakwattana. Preventive effect of grape seed extract against high-fructose diet-induced insulin resistance and oxidative stress in rats. Food Chem. Toxicol. 48: 1853-1857, 2010.
32. Timar, O., F. Sestier and E. Levy. Metabolic syndrome X: A review. Can. J. Cardiol. 16: 779-789, 2000.
33. Vasudevan, H., P.R. Nagareddy and J.H. McNeill. Gonadectomy prevents endothelial dysfunction in fructose-fed male rats, a factor contributing to the development of hypertension. Am. J. Physiol. Heart Circ. Physiol. 291: H3058-H3064, 2006.
34. Villar, I.C., R. Vera, M. Galisteo, F. O'Valle, M. Romero, A. Zarzuelo and J. Duarte. Endothelial nitric oxide production stimulated by the bioflavonoid chrysin in rat isolated aorta. Planta Med. 71: 829-834, 2005.
35. Williams, C.A., J.B. Harborne, M. Newman, J. Greenham and J. Eagles. Chrysin and other leaf exudate flavonoids in the genus Pelargonium. Phytochemistry 46: 1349-1353, 1997.
36. Xavier, F.E., A.P. Davel, L.V. Rossoni and D.V. Vassallo. Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: Role of prostanoids and calcium mobilization. Vascul. Pharmacol. 40: 67-76, 2003.
37. Zanoli, P., R. Avallone and M. Baraldi. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia 71(Suppl 1): S117-S123, 2000.
38. Zhang, J., B.H. Zhang, Y.R. Yu, C.S. Tang and Y.F. Qi. Adrenomedullin protects against fructoseinduced insulin resistance and myocardial hypertrophy in rats. Peptides 32: 1415-1421, 2011.